newto.ca

Gefitinib is a widely used targeted therapy for the treatment of non-small cell lung cancer (NSCLC). As an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, it works by blocking cancer cell growth and preventing the spread of tumors. Gefitinib is particularly effective in patients w...